Intel's foundry business reported a significant $2.5 billion loss in Q4, and the company's Q1 2026 revenue guidance missed consensus expectations, raising concerns about its turnaround momentum despite a strong 2025 rally. CEO commentary highlighted challenges in scaling foundry operations, which contributed to a notable decline in Intel's stock price in February, testing the rally momentum from early 2025. Looking ahead, early 2026 presents a critical period for the stock's performance as it navigates these operational headwinds.
Adding to recent pressures, Intel is facing bipartisan U.S. Congressional scrutiny over its use of chip manufacturing equipment linked to China, with lawmakers expressing national security concerns. While Intel asserts compliance with U.S. regulations and states the equipment is not used in production, the scrutiny could lead to increased regulatory oversight. Concurrently, the company appointed a new board chair, Dr. Craig H. Barratt, as governance and security issues come to the forefront.
On a more positive note, Intel's Data Center and AI Group (DCAI) segment has achieved its fastest sequential revenue growth in a decade, with custom AI processor revenue now exceeding a $1 billion annual run rate. Management anticipates supply constraints will ease and margin expansion will begin in Q2 2026, supporting a positive outlook driven by potential turnaround strategies and an expanding custom ASIC market presence. Intel is also indirectly highlighted as a key player in the AI ecosystem, relying on specific technology providers for its operations. Investors should watch for updates on the scaling of foundry operations and the resolution of regulatory scrutiny.